Oncology Institute, Inc. (TOI) has 13 SEC Form 4 insider filings on record in the last 90 days. That includes 3 insider purchases totalling $273K. Most recent filing: July 29, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| July 29, 2026 filed July 27, 2026 | Kaushal Mohit Director | $0 | 33,133 | +19% | No | |
|
|
||||||
| July 29, 2026 filed July 27, 2026 | McGeorge Anne Director | $0 | 41,165 | +14% | No | |
|
|
||||||
| July 29, 2026 filed July 27, 2026 | Pacala Mark L Director | $0 | 30,120 | +12% | No | |
|
|
||||||
| July 29, 2026 filed July 27, 2026 | STOLPER MARK Director | $0 | 31,124 | +120% | No | |
|
|
||||||
| July 29, 2026 filed July 27, 2026 | TZOUMAKAS KIMBERLY JO Director | $0 | 29,116 | +169% | No | |
|
|
||||||
Showing the 5 most recent of 13 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free